Clinical Trial Update: Self-Consent for PrEP Perspectives

View source ↗

Summary

This clinical trial update discusses self-consent perspectives for PrEP in HIV prevention, sponsored by the University of North Carolina at Chapel Hill. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV, PrEP | Status: COMPLETED